6501-31-1 Usage
Uses
Used in Organic Synthesis:
(4-PROPIONYL-PHENOXY)-ACETIC ACID is used as a key intermediate in organic synthesis for its ability to participate in numerous chemical reactions, facilitating the creation of a broad range of compounds.
Used in Pharmaceutical Research:
In pharmaceutical research, (4-PROPIONYL-PHENOXY)-ACETIC ACID is utilized as a building block for the development of new drugs and pharmaceuticals. Its unique chemical properties and structure make it a promising candidate for creating innovative therapeutic agents.
Used in Drug Development:
(4-PROPIONYL-PHENOXY)-ACETIC ACID holds potential in the development of new drugs due to its capacity to be modified and incorporated into various molecular frameworks, contributing to the advancement of medicinal chemistry.
Used in Specialty Chemicals and Materials Production:
(4-PROPIONYL-PHENOXY)-ACETIC ACID may also find applications in industrial settings, particularly in the production of specialty chemicals and materials, where its distinctive structure and reactivity can be harnessed to create high-value products.
Check Digit Verification of cas no
The CAS Registry Mumber 6501-31-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,0 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6501-31:
(6*6)+(5*5)+(4*0)+(3*1)+(2*3)+(1*1)=71
71 % 10 = 1
So 6501-31-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H12O4/c1-2-10(12)8-3-5-9(6-4-8)15-7-11(13)14/h3-6H,2,7H2,1H3,(H,13,14)
6501-31-1Relevant academic research and scientific papers
Ethacrynic acid analogues lacking the α,β-unsaturated carbonyl unit-Potential anti-metastatic drugs
Janser, Romy F.J.,Meka, Ranjith K.,Bryant, Zack E.,Adogla, Enoch A.,Vogel, Elizabeth K.,Wharton, Jaimie L.,Tilley, Cynthia M.,Kaminski, Catherine N.,Ferrey, Seth L.,Van slambrouck, Severine,Steelant, Wim F.A.,Janser, Ingo
experimental part, p. 1848 - 1850 (2010/07/06)
A series of ethacrynic acid analogues, lacking the α,β-unsaturated carbonyl unit, was synthesized and subsequently evaluated for their ability to inhibit the migration of human breast cancer cells, MCF-7/AZ. Several of the analogues were already active in the low micromolar range, whereas ethacrynic acid itself shows no potential to inhibit the migration of these cancer cells. Preliminary studies show that the presence of one or more methoxy groups at the phenyl ring of ethacrynic acid is important in order for the ethacrynic acid analogues to demonstrate an inhibitory effect on the migration.
